Vitamin D Status in Full-term Exclusive Breastfed Infants versus Full-term Breastfed Infants Receiving Vitamin D Supplement in Thailand

Completed

• Conditions: Exclusively breastfed Full-term infants at the age 2-3 months; Exclusively Breastfed, Full-term infants, Vitamin D supplement

• Registration Number: TCTR20190622001
• Lead Sponsor: Faculty of Medicine Ramathibodi Hospital

Brief Summary

The infants' serum 25OHD concentration was lower in the control group than intervention group. More infants had vitamin D sufficiency (25OHD of more than 20 ng/mL) in the intervention group than the control group. There were no significant differences in the maternal 25OHD concentrations between the control and intervention groups. Serum calcium, phosphorus, intact parathyroid hormone, alkaline phosphatase, and infants' growth parameters were comparable between the two groups.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-06-22
• Study Completion: 2020-10-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 87

Inclusion Criteria

Only the mothers of full-term, healthy infants who have been successfully exclusively breastfed and have an intention to exclusively breastfeeding until the infant turn 6 months will be eligible to participate in the trial.

Exclusion Criteria

- Infants with congenital anomaly
- Any formula-feeding infants

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Infant vitamin D level at the age of 6 months serum 25OHD level (LC-MS)

Secondary Outcome Measures

Name	Time	Method
Infant calcium level at the age of 6 months serum calcium level,Infant PTH level at the age of 6 months serum PTH level,Infant phosphorous level at the age of 6 months serum phosphorous level,Infant ALP level at the age of 6 months serum ALP level,Mother vitamin D level when infant turn 6 months serum 25OHD level (LC-MS)